To test our hypothesis, we not only assessed the correlation between the expression of the newly identified JAK3-INSL3 fusion transcript with clinical data from SS patients, but also conducted in vitro and in vivo experiments with established CTCL cell lines. Here, JAK3 is linked to synovial sarcoma.